NEWS
UTOPIA AND CROWDFUNDME TOGETHER TO SUPPORT CASREVOLUTION’S CAPITAL RAISING
Milan, November 30, 2023 - Utopia SIS, a Simple Investment Company operating in the Life Sciences sector, and CrowdFundMe SpA, a crowdinvesting portal listed on the Italian Stock Exchange, are launching a collaboration for the success of the capital raise of...
Utopia SIS invests 1.5 million euros in DDC
Drug Discovery & Clinic S.r.l. (DDC), a spin-off of the University of Turin dedicated to the development of a platform for the creation of potentially effective drugs for different oncological scenarios, namely leukemia and breast cancer. Utopia SIS, the...
Utopia SIS invests 2.5 million euros in T One Therapeutics
Spin of INGM, the National Institute of Molecular Genetics “Romeo and Enrica Invernizzi”, dedicated to the development of new anti-tumor immunotherapies based on the blockade of epigenetic signals that regulate the dominant immunosuppression in tumor tissues. Bologna,...
Utopia SIS invests in PerFormS
PerFormS Srl is a spin-off of the University of Modena and Reggio Emilia, accompanied in its development in recent years by the G-Factor incubator of Fondazione Golinelli in Bologna. The investment will be covered by the guarantee of the Medio Credito Centrale for 80%...
Utopia SIS and Pariter Partners invest in Lighthouse Biotech
Lighthouse Biotech aims to define new boundaries for oncology research through new liquid biopsy technologies The investment will be the first to be guaranteed by Medio Credito Centrale for over 80% Milan, December 29, 2021 - Utopia SIS, an investment company...
Alfasigma, Utopia SIS, Istituto David Chiossone e Club2021 (famiglia Taini) entrano nella start-up Novavido
The 6 million euro round is underway with two tranches of capital increase of the start-up already accelerated by G-Factor of the Golinelli Foundation and developed thanks to the scientific research of IIT and the Don Calabria Hospital in Negrar. The project focuses...